<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>PROSPECTS FOR APPLICATION OF DNA COMPUTING IN ROBOTIC TECHNOLOGIES IN MEDICINE</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Nodira</mods:namePart><mods:namePart type="family">Xolbayeva</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>One of the main challenges in cancer treatment is achieving selective action on tumor cells without causing damage to healthy cells. Over the past five years, DNA-based nanorobots have attracted significant scientific interest as an innovative approach aimed at solving this problem. DNA nanorobots are distinguished by their molecular-level programmability, biocompatibility, and high selectivity. In the future, advances in molecular nanotechnology are expected to significantly expand medical treatments while reducing risks and costs. DNA-based nanobots are already capable of identifying up to 12 types of cancer cells. With recent research and technological developments, these nanorobots are expected to bring a fundamental breakthrough in medicine for the benefit of humanity. It is anticipated that nanorobots may become accessible to the general population within the next five years.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-04-15</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Conferences</mods:publisher></mods:originInfo><mods:genre>Article</mods:genre></mods:mods>